By: Dr. David Rabiner
Problems with sleep are common in children with ADHD; in fact, past studies indicate that sleep problems occur in between 70 and 85%. Because of this, the American Academy of Pediatrics recommends that sleep difficulties should be assessed as part of a comprehensive ADHD evaluation. In some children, significant sleep difficulties may be an important contributor to apparent ADHD symptoms, and could contribute to a child being incorrectly diagnosed. For example, Read the rest of this entry »
Time for a new edition of SharpBrains’ e-newsletter exploring the latest digital brain health technologies, neuroscience findings and insights for lifelong brain health and mental health.
Finally, here you are a fun brain teaser to challenge your frontal lobes.
We hope you enjoy all the neuro-stimulating reading 🙂
The SharpBrains Team
By: Apoorv Mathur
Last year I got very interested in the functioning of the human brain and the science behind mindfulness and learning , so was quite excited to attend the SharpBrains Virtual Summit  in December, indulging in the latest trends in applied neuroscience and digital innovation.
The Summit focused on the theme of reinventing brain health in the digital age, and brought together leading researchers, entrepreneurs, financiers and policymakers passionate with the mission of moving neuroscience and cognitive research from science labs towards applications in Health, Wellness and Education. Here’s a summary of the many things I discovered. Read the rest of this entry »
By: Dr. David Rabiner
Although medication is the primary treatment for adults with ADHD, and has good empirical support, many adults would rather not take it. For these adults with ADHD, it would be helpful to know whether medication is likely to provide significant benefits above and beyond those they would gain from well-conducted therapy, or whether they are likely to derive roughly equivalent benefits from therapy alone. Read the rest of this entry »
Two digital health entrepreneurs–who have collectively raised over $50 million in venture capital in the last 18 months– and an investor discuss their respective visions and approaches to revolutionize brain and mental health in areas such as ADHD, substance abuse, and general brain fitness.
- Chair: Rita Carter, Science writer and BBC Contributor
- Edward Kliphuis, Investment Director at Merck Ventures
- Dr. Eddie Martucci, CEO of Akili Interactive Labs
- Dr. Corey McCann, CEO of Pear Therapeutics
This presentation took place at the 2016 SharpBrains Virtual Summit: Reinventing Brain Health in the Digital Age (December 6-8th, 2016).